Helen of Troy Limited Reports Third Quarter Fiscal 2023 Results
Helen of Troy Limited (NASDAQ: HELE) reported a 10.6% decline in consolidated net sales for Q3 Fiscal 2023, totaling $558.6 million, compared to $624.9 million in Q3 Fiscal 2022. The GAAP diluted EPS fell 30.6% to $2.15, while Core adjusted diluted EPS decreased 26.1% to $2.75. The company has updated its Fiscal 2023 outlook, expecting net sales between $2.025 billion and $2.050 billion and GAAP diluted EPS to range from $4.82 to $5.11. They also announced restructuring efforts under Project Pegasus, aiming for operational cost savings.
- Consolidated gross profit margin increased to 45.9% from 43.8% due to a favorable mix of sales.
- Core net sales are up 33.1% compared to pre-COVID levels in Fiscal 2020.
- Significant progress on Project Pegasus aims for annualized profit improvements of $75 million to $85 million.
- Consolidated net sales fell 10.6% year-over-year, with a 18.5% decline from Organic business.
- Core adjusted diluted EPS declined 26.1%, indicating ongoing profitability challenges.
- Interest expenses rose to $13.1 million, significantly up from $3.2 million, due to increased debt levels.
Consolidated Net Sales Decline of
Core Net Sales Decline of
GAAP Diluted EPS of
Core Adjusted Diluted EPS Decline of
Updates Fiscal 2023 Net Sales and Diluted EPS Outlook:
Consolidated
Consolidated Diluted EPS to
Provides Update on Project Pegasus
Executive Summary – Third Quarter of Fiscal 2023 Compared to Fiscal 2022, Fiscal 2021 and Fiscal 2020
-
Consolidated net sales revenue was
, a decrease of$558.6 million 10.6% from fiscal 2022, a decrease of12.4% from fiscal 2021, and an increase of17.7% from fiscal 2020
-
Core business net sales decrease of
10.0% from fiscal 2022, a decrease of9.6% from fiscal 2021, and an increase of23.9% from fiscal 2020
-
GAAP diluted EPS of
, compared to$2.15 for the same period last year,$3.10 for fiscal 2021, and$3.34 for fiscal 2020$2.71
-
Non-GAAP Core adjusted diluted EPS of
, a decrease of$2.75 26.1% from fiscal 2022, a decrease of23.8% from fiscal 2021, and a decrease of7.7% from fiscal 2020
-
Non-GAAP adjusted diluted EPS of
, a decrease of$2.75 26.1% from fiscal 2022, a decrease of26.9% from fiscal 2021, and a decrease of11.9% from fiscal 2020
“Regarding our outlook for this fiscal year, we are raising the bottom of our range for both sales and adjusted EPS. Consumption remains soft in certain of our categories and some retailers are continuing to reduce their orders as they sell down their inventory. We are, however, encouraged to see trade inventory at some key retailers start to better align with sell through, as well as stabilization and modest improvement in market share for certain categories such as Beauty appliances.”
|
Three Months Ended |
||||||||||||||
(in thousands) (unaudited) |
Home & Outdoor |
|
Health & Wellness |
|
Beauty |
|
Total |
||||||||
Fiscal 2022 sales revenue, net |
$ |
246,135 |
|
|
$ |
203,900 |
|
|
$ |
174,849 |
|
|
$ |
624,884 |
|
Organic business (1) |
|
(57,262 |
) |
|
|
(22,046 |
) |
|
|
(36,242 |
) |
|
|
(115,550 |
) |
Impact of foreign currency |
|
(3,191 |
) |
|
|
(1,371 |
) |
|
|
(2,512 |
) |
|
|
(7,074 |
) |
Acquisition (2) |
|
43,255 |
|
|
|
— |
|
|
|
13,091 |
|
|
|
56,346 |
|
Change in sales revenue, net |
|
(17,198 |
) |
|
|
(23,417 |
) |
|
|
(25,663 |
) |
|
|
(66,278 |
) |
Fiscal 2023 sales revenue, net |
$ |
228,937 |
|
|
$ |
180,483 |
|
|
$ |
149,186 |
|
|
$ |
558,606 |
|
|
|
|
|
|
|
|
|
||||||||
Total net sales revenue growth (decline) |
|
(7.0 |
) % |
|
|
(11.5 |
) % |
|
|
(14.7 |
) % |
|
|
(10.6 |
) % |
Organic business |
|
(23.3 |
) % |
|
|
(10.8 |
) % |
|
|
(20.7 |
) % |
|
|
(18.5 |
) % |
Impact of foreign currency |
|
(1.3 |
) % |
|
|
(0.7 |
) % |
|
|
(1.4 |
) % |
|
|
(1.1 |
) % |
Acquisition |
|
17.6 |
% |
|
|
— |
% |
|
|
7.5 |
% |
|
|
9.0 |
% |
|
|
|
|
|
|
|
|
||||||||
Operating margin (GAAP) |
|
|
|
|
|
|
|
||||||||
Fiscal 2023 |
|
13.5 |
% |
|
|
11.8 |
% |
|
|
16.8 |
% |
|
|
13.8 |
% |
Fiscal 2022 |
|
17.6 |
% |
|
|
6.7 |
% |
|
|
19.0 |
% |
|
|
14.4 |
% |
Adjusted operating margin (non-GAAP) |
|
|
|
|
|
|
|
||||||||
Fiscal 2023 |
|
17.4 |
% |
|
|
11.8 |
% |
|
|
21.1 |
% |
|
|
16.6 |
% |
Fiscal 2022 |
|
19.4 |
% |
|
|
10.7 |
% |
|
|
20.9 |
% |
|
|
17.0 |
% |
|
Three Months Ended |
|
% Change |
|||||||||||||||||
(in thousands, except per share data) (unaudited) |
2022 |
|
2021 |
|
2020 |
|
2019 |
|
FY23/FY22 |
|
FY23/FY21 |
|
FY23/FY20 |
|||||||
Consolidated net sales revenue |
$ |
558,606 |
|
$ |
624,884 |
|
$ |
637,737 |
|
$ |
474,737 |
|
(10.6 |
) % |
|
(12.4 |
) % |
|
17.7 |
% |
Core business net sales revenue (3) |
|
558,606 |
|
|
620,509 |
|
|
617,766 |
|
|
450,742 |
|
(10.0 |
) % |
|
(9.6 |
) % |
|
23.9 |
% |
Leadership Brand net sales revenue (4) |
|
451,500 |
|
|
506,982 |
|
|
508,210 |
|
|
379,604 |
|
(10.9 |
) % |
|
(11.2 |
) % |
|
18.9 |
% |
Online channel net sales revenue (5) |
|
145,577 |
|
|
141,233 |
|
|
152,562 |
|
|
114,193 |
|
3.1 |
% |
|
(4.6 |
) % |
|
27.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Consolidated Diluted EPS |
$ |
2.15 |
|
$ |
3.10 |
|
$ |
3.34 |
|
$ |
2.71 |
|
(30.6 |
) % |
|
(35.6 |
) % |
|
(20.7 |
) % |
Consolidated Adjusted Diluted EPS (non-GAAP) (6) |
|
2.75 |
|
|
3.72 |
|
|
3.76 |
|
|
3.12 |
|
(26.1 |
) % |
|
(26.9 |
) % |
|
(11.9 |
) % |
Core Adjusted Diluted EPS (non-GAAP) (3) (6) |
|
2.75 |
|
|
3.72 |
|
|
3.61 |
|
|
2.98 |
|
(26.1 |
) % |
|
(23.8 |
) % |
|
(7.7 |
) % |
|
Nine Months Ended |
|
% Change |
|||||||||||||||||
(in thousands, except per share data) (unaudited) |
2022 |
|
2021 |
|
2020 |
|
2019 |
|
FY23/FY22 |
|
FY23/FY21 |
|
FY23/FY20 |
|||||||
Consolidated net sales revenue |
$ |
1,588,084 |
|
$ |
1,641,335 |
|
$ |
1,589,424 |
|
$ |
1,265,067 |
|
(3.2 |
) % |
|
(0.1 |
) % |
|
25.5 |
% |
Core business net sales revenue (3) |
|
1,588,084 |
|
|
1,611,098 |
|
|
1,526,995 |
|
|
1,193,454 |
|
(1.4 |
) % |
|
4.0 |
% |
|
33.1 |
% |
Leadership Brand net sales revenue (4) |
|
1,338,849 |
|
|
1,329,858 |
|
|
1,288,614 |
|
|
1,012,346 |
|
0.7 |
% |
|
3.9 |
% |
|
32.3 |
% |
Online channel net sales revenue (5) |
|
372,762 |
|
|
369,007 |
|
|
398,175 |
|
|
299,901 |
|
1.0 |
% |
|
(6.4 |
) % |
|
24.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Consolidated Diluted EPS |
$ |
4.45 |
|
$ |
7.52 |
|
$ |
9.14 |
|
$ |
6.15 |
|
(40.8 |
) % |
|
(51.3 |
) % |
|
(27.6 |
) % |
Consolidated Adjusted Diluted EPS (non-GAAP) (6) |
|
7.44 |
|
|
9.85 |
|
|
10.05 |
|
|
7.42 |
|
(24.5 |
) % |
|
(26.0 |
) % |
|
0.3 |
% |
Core Adjusted Diluted EPS (non-GAAP) (3) (6) |
|
7.44 |
|
|
9.67 |
|
|
9.58 |
|
|
6.98 |
|
(23.1 |
) % |
|
(22.3 |
) % |
|
6.6 |
% |
During the fourth quarter of fiscal 2020, the Company committed to a plan to divest certain assets within its Beauty segment's mass channel personal care business (“Personal Care”). On
|
Three Months Ended |
||||||||||||||
(in thousands) (unaudited) |
Home & Outdoor |
|
Health & Wellness |
|
Beauty |
|
Total |
||||||||
Fiscal 2022 sales revenue, net |
$ |
246,135 |
|
|
$ |
203,900 |
|
|
$ |
174,849 |
|
|
$ |
624,884 |
|
Core business (3) |
|
(17,198 |
) |
|
|
(23,417 |
) |
|
|
(21,288 |
) |
|
|
(61,903 |
) |
Non-Core business (Personal Care) (3) |
|
— |
|
|
|
— |
|
|
|
(4,375 |
) |
|
|
(4,375 |
) |
Change in sales revenue, net |
|
(17,198 |
) |
|
|
(23,417 |
) |
|
|
(25,663 |
) |
|
|
(66,278 |
) |
Fiscal 2023 sales revenue, net |
$ |
228,937 |
|
|
$ |
180,483 |
|
|
$ |
149,186 |
|
|
$ |
558,606 |
|
|
|
|
|
|
|
|
|
||||||||
Total net sales revenue decline |
|
(7.0 |
) % |
|
|
(11.5 |
) % |
|
|
(14.7 |
) % |
|
|
(10.6 |
) % |
Core business |
|
(7.0 |
) % |
|
|
(11.5 |
) % |
|
|
(12.2 |
) % |
|
|
(9.9 |
) % |
Non-Core business (Personal Care) |
|
— |
% |
|
|
— |
% |
|
|
(2.5 |
) % |
|
|
(0.7 |
) % |
Consolidated Results - Third Quarter Fiscal 2023 Compared to Third Quarter Fiscal 2022
-
Consolidated net sales revenue decreased
, or$66.3 million 10.6% , to compared to$558.6 million . The decline was primarily driven by a decrease from Organic business of$624.9 million , or$115.6 million 18.5% . The Organic business decrease primarily reflects lower sales in all segments due to lower consumer demand, shifts in consumer spending patterns, reduced orders from retail customers due to higher trade inventory levels, the unfavorable comparative impact of approximately from earlier than typical customer orders in the third quarter of fiscal 2022 as retailers accelerated orders to try to avoid supply chain disruptions during the prior year holiday season, and a net sales revenue decline of$15 million in Non-Core business due to the sale of the Personal Care business. These factors were partially offset by the favorable impact of customer price increases related to rising freight and product costs, higher closeout channel sales in the Home & Outdoor segment and an increase in sales of humidification products in the Health & Wellness segment. The Organic business decline was partially offset by the contribution from the acquisitions of Osprey of$4.4 million and Curlsmith of$43.3 million , or$13.1 million 9.0% to consolidated net sales revenue.
-
Consolidated gross profit margin increased 2.1 percentage points to
45.9% , compared to43.8% . The increase in consolidated gross profit margin was primarily due to a favorable mix of more Home & Outdoor sales within consolidated net sales revenue, a more favorable customer mix within the Home & Outdoor segment, and a more favorable product mix within the Beauty segment primarily due to the acquisition of Curlsmith. These factors were partially offset by a less favorable product mix within the Home & Outdoor segment due to the acquisition of Osprey and the net dilutive impact of inflationary costs and related customer price increases.
-
Consolidated selling, general and administrative expense (“SG&A”) ratio increased 0.9 percentage points to
30.3% , compared to29.4% . The increase in the consolidated SG&A ratio was primarily due to unfavorable operating leverage, higher salary and wage costs, higher marketing expense, increased amortization expense, higher outbound freight costs, and higher share-based compensation expense. These factors were partially offset by a gain from insurance recoveries on damaged inventory of , reduced annual incentive compensation expense, the favorable leverage impact of customer price increases related to inflationary costs, a decrease in$9.7 million EPA compliance costs of , and the favorable comparative impact of acquisition-related expense incurred in connection with the Osprey transaction during the prior year period.$2.9 million
-
Consolidated operating income was
, or$77.2 million 13.8% of net sales revenue, compared to , or$90.0 million 14.4% of net sales revenue. The 0.6 percentage point decrease in consolidated operating margin was primarily due to unfavorable operating leverage, restructuring charges of , the unfavorable impact of less Beauty segment sales within consolidated net sales revenue, a less favorable product mix within the Home & Outdoor segment due to the acquisition of Osprey, higher salary and wage costs, an increase in outbound freight costs, increased amortization expense, and higher share-based compensation expense. These factors were partially offset by a gain from insurance recoveries on damaged inventory of$10.5 million , reduced annual incentive compensation expense, a decrease in$9.7 million EPA compliance costs of , the favorable comparative impact of acquisition-related expense incurred in connection with the Osprey transaction during the prior year period, a more favorable customer mix within the Home & Outdoor segment, and a more favorable product mix within the Beauty segment primarily due to the acquisition of Curlsmith.$2.8 million
-
Interest expense was
, compared to$13.1 million . The increase in interest expense was primarily due to higher average levels of debt outstanding, including borrowings to fund the acquisitions of Osprey and Curlsmith as well as construction of the previously-announced new distribution center in$3.2 million Tennessee , and higher average interest rates compared to the same period last year.
-
Income tax expense as a percentage of income before income tax was
19.1% compared to12.9% , primarily due to lower forecasted annual income before income tax and shifts in the mix of income in various tax jurisdictions, which were partially offset by increased tax benefits for discrete items.
-
Net income was
, compared to$51.8 million . Diluted EPS was$75.7 million , compared to$2.15 . Diluted EPS decreased primarily due to lower operating income in the Home & Outdoor and Beauty segments, higher interest expense and an increase in the effective income tax rate. These factors were partially offset by higher operating income in the Health & Wellness segment and lower weighted average diluted shares outstanding.$3.10
-
Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) decreased
10.8% to compared to$99.7 million .$111.8 million
On an adjusted basis for the third quarters of fiscal 2023 and 2022, excluding acquisition-related expenses,
-
Adjusted operating income decreased
, or$13.4 million 12.7% , to , or$92.7 million 16.6% of net sales revenue, compared to , or$106.1 million 17.0% of net sales revenue. The 0.4 percentage point decrease in adjusted operating margin is primarily driven by unfavorable operating leverage, the unfavorable impact of less Beauty segment sales within consolidated net sales revenue, a less favorable product mix within the Home & Outdoor segment due to the acquisition of Osprey, higher salary and wage costs, and an increase in outbound freight costs. These factors were partially offset by reduced annual incentive compensation expense, a more favorable customer mix within the Home & Outdoor segment, and a more favorable product mix within the Beauty segment primarily due to the acquisition of Curlsmith.
-
Adjusted income decreased
, or$24.4 million 26.9% , to , compared to$66.3 million for the same period last year. Adjusted diluted EPS decreased$90.6 million 26.1% to compared to$2.75 . The decrease in adjusted diluted EPS was primarily due to lower adjusted operating income, higher interest expense and an increase in the effective income tax rate. These factors were partially offset by lower weighted average diluted shares outstanding.$3.72
Segment Results - Third Quarter Fiscal 2023 Compared to Third Quarter Fiscal 2022
Home & Outdoor net sales revenue decreased
Health & Wellness net sales revenue decreased
Beauty net sales revenue decreased
Balance Sheet and Cash Flow Highlights - Third Quarter Fiscal 2023 Compared to Third Quarter Fiscal 2022
-
Cash and cash equivalents totaled
, compared to$45.3 million .$44.3 million
- Accounts receivable turnover was 70.6 days, compared to 70.4 days.
-
Inventory was
, compared to$536.8 million . Trailing twelve-month inventory turnover was 2.1 times, compared to 2.3 times.$585.8 million
-
Total short- and long-term debt was
, compared to$1,080.5 million , primarily due to the acquisitions of Osprey and Curlsmith as well as investments in construction of the new distribution center.$447.5 million
-
Net cash provided by operating activities for the first nine months of the fiscal year was
, compared to net cash used by operating activities of$49.5 million for the same period last year.$5.1 million
-
For the first nine months of the fiscal year, net cash used by investing activities of
included investments to acquire Curlsmith for$290.7 million and capital asset expenditures of$147.9 million for construction of the new distribution center.$125.8 million
Restructuring Plan
The Company previously announced a global restructuring plan intended to expand operating margins through initiatives designed to improve effectiveness and efficiency (collectively referred to as “Project Pegasus”). Project Pegasus, under the leadership of the Chief Operating Officer,
As part of the Pegasus workstream focused on streamlining and simplifying the organization, the Company is announcing three major changes to the structure of its organization. The first change results in combining the Beauty and Health & Wellness businesses into a single reportable segment that will be referred to and reported as “Beauty & Wellness.” The second is the creation of a
Consistent with the second quarter of fiscal 2023, the Company continues to have the following expectations regarding Project Pegasus:
-
Targeted annualized pre-tax operating profit improvements of approximately
to$75 million , which the Company expects to begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026.$85 million
-
Estimated cadence of the recognition of the savings will be approximately
25% in fiscal 2024, approximately50% in fiscal 2025 and approximately25% in fiscal 2026.
-
Total profit improvements to be realized approximately
60% through reduced cost of goods sold and40% through lower SG&A.
-
Total one-time pre-tax restructuring charges of approximately
to$85 million over the duration of the plan, which is expected to be completed during fiscal 2025 and will primarily be comprised of severance and employee related costs, professional fees, contract termination costs, and other exit and disposal costs.$95 million
- All of the Company's operating segments and shared services will be impacted by the plan.
Updated Fiscal 2023 Annual Outlook
The Company believes that Core business growth is the most relevant basis, as it provides the best comparability between historical and future periods. Due to the sale of the Personal Care business, the Company is not currently expecting any material activity related to Non-Core business in fiscal 2023. Therefore, the amounts included in its updated outlook for fiscal 2023 will be shown on a consolidated basis. However, due to the fact that the fiscal 2022 results include material activity related to Non-Core business, the year-over-year growth rates on a consolidated and Core business basis will be different. Where appropriate, the information provided in the outlook will reflect growth rates on both a consolidated and Core business basis.
The Company now expects consolidated net sales revenue in the range of
The Company’s updated fiscal year net sales outlook reflects the following expectations by segment:
-
Home & Outdoor net sales growth of
2.5% to3.5% ; including net sales from Osprey of to$180 million ;$185 million
-
Health & Wellness net sales decline of
11% to10% ; and
-
Beauty Core business net sales decline of18.5% to17.5% ; including net sales from Curlsmith of to$35 million .$40 million
The Company now expects consolidated GAAP diluted EPS of
The Company’s updated consolidated net sales and EPS outlooks reflect the following assumptions:
- the assumption that the severity of the cough/cold/flu season will be higher than pre-COVID historical averages;
-
December 2022 foreign currency exchange rates will remain constant for the remainder of the fiscal year;
-
the estimated net favorable impact to net sales of approximately
and adjusted diluted EPS of approximately$10 million related to the$0.10 EPA matter;
-
estimated incremental after-tax inflationary cost pressures in the range of
to$50 million , or approximately$55 million to$2.10 of adjusted diluted EPS;$2.25
-
expected interest expense of
to$42 million based on the current assumption that the$43 million Federal Open Market Committee will increase interest rates by 450 basis points during calendar year 2022;
-
a reported consolidated GAAP effective tax rate range of
19.5% to19.9% for the full fiscal year 2023 and a consolidated adjusted effective tax rate range of13.1% to13.6% ; and
- an estimated weighted average diluted shares outstanding of 24.1 million.
The Company now expects capital and intangible asset expenditures of
The likelihood and potential impact of any fiscal 2023 acquisitions and divestitures, future asset impairment charges, future foreign currency fluctuations, or further share repurchases are unknown and cannot be reasonably estimated; therefore, they are not included in the Company’s updated outlook.
Conference Call and Webcast
The Company will conduct a teleconference in conjunction with today’s earnings release. The teleconference begins at
Non-GAAP Financial Measures
The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in
About
For more information about Helen of Troy, please visit http://investor.helenoftroy.com
Forward-Looking Statements
Certain written and oral statements made by the Company and subsidiaries of the Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this press release, in other filings with the
HELEN OF TROY LIMITED AND SUBSIDIARIES
|
|||||||||||
|
Three Months Ended |
||||||||||
|
2022 |
|
2021 |
||||||||
Sales revenue, net |
$ |
558,606 |
|
100.0 |
% |
|
$ |
624,884 |
|
100.0 |
% |
Cost of goods sold |
|
301,930 |
|
54.1 |
% |
|
|
351,051 |
|
56.2 |
% |
Gross profit |
|
256,676 |
|
45.9 |
% |
|
|
273,833 |
|
43.8 |
% |
Selling, general and administrative expense (“SG&A”) |
|
169,020 |
|
30.3 |
% |
|
|
183,788 |
|
29.4 |
% |
Restructuring charges |
|
10,463 |
|
1.9 |
% |
|
|
5 |
|
— |
% |
Operating income |
|
77,193 |
|
13.8 |
% |
|
|
90,040 |
|
14.4 |
% |
Non-operating income, net |
|
5 |
|
— |
% |
|
|
52 |
|
— |
% |
Interest expense |
|
13,149 |
|
2.4 |
% |
|
|
3,206 |
|
0.5 |
% |
Income before income tax |
|
64,049 |
|
11.5 |
% |
|
|
86,886 |
|
13.9 |
% |
Income tax expense |
|
12,223 |
|
2.2 |
% |
|
|
11,203 |
|
1.8 |
% |
Net income |
$ |
51,826 |
|
9.3 |
% |
|
$ |
75,683 |
|
12.1 |
% |
|
|
|
|
|
|
|
|
||||
Diluted earnings per share (“EPS”) |
$ |
2.15 |
|
|
|
$ |
3.10 |
|
|
||
|
|
|
|
|
|
|
|
||||
Weighted average shares of common stock used in computing diluted EPS |
|
24,078 |
|
|
|
|
24,399 |
|
|
||
|
Nine Months Ended |
||||||||||
|
2022 |
|
2021 |
||||||||
Sales revenue, net |
$ |
1,588,084 |
|
100.0 |
% |
|
$ |
1,641,335 |
|
100.0 |
% |
Cost of goods sold |
|
898,791 |
|
56.6 |
% |
|
|
936,322 |
|
57.0 |
% |
Gross profit |
|
689,293 |
|
43.4 |
% |
|
|
705,013 |
|
43.0 |
% |
SG&A |
|
515,974 |
|
32.5 |
% |
|
|
482,467 |
|
29.4 |
% |
Restructuring charges |
|
15,241 |
|
1.0 |
% |
|
|
380 |
|
— |
% |
Operating income |
|
158,078 |
|
10.0 |
% |
|
|
222,166 |
|
13.5 |
% |
Non-operating income, net |
|
185 |
|
— |
% |
|
|
185 |
|
— |
% |
Interest expense |
|
26,688 |
|
1.7 |
% |
|
|
9,508 |
|
0.6 |
% |
Income before income tax |
|
131,575 |
|
8.3 |
% |
|
|
212,843 |
|
13.0 |
% |
Income tax expense |
|
24,482 |
|
1.5 |
% |
|
|
28,873 |
|
1.8 |
% |
Net income |
$ |
107,093 |
|
6.7 |
% |
|
$ |
183,970 |
|
11.2 |
% |
|
|
|
|
|
|
|
|
||||
Diluted EPS |
$ |
4.45 |
|
|
|
$ |
7.52 |
|
|
||
|
|
|
|
|
|
|
|
||||
Weighted average shares of common stock used in computing diluted EPS |
|
24,086 |
|
|
|
|
24,461 |
|
|
||
Condensed Consolidated Statements of Income and Reconciliation of Non-GAAP
|
||||||||||||||||
|
Three Months Ended |
|||||||||||||||
|
As Reported
|
|
Adjustments |
|
Adjusted
|
|||||||||||
Sales revenue, net |
$ |
558,606 |
|
100.0 |
% |
|
$ |
— |
|
|
$ |
558,606 |
|
100.0 |
% |
|
Cost of goods sold |
|
301,930 |
|
54.1 |
% |
|
|
(370 |
) |
(7 |
) |
|
301,560 |
|
54.0 |
% |
Gross profit |
|
256,676 |
|
45.9 |
% |
|
|
370 |
|
|
|
257,046 |
|
46.0 |
% |
|
SG&A |
|
169,020 |
|
30.3 |
% |
|
|
(1,733 |
) |
(7 |
) |
|
164,370 |
|
29.4 |
% |
|
|
|
|
|
|
9,676 |
|
(8 |
) |
|
|
|
||||
|
|
|
|
|
|
(4,652 |
) |
(9 |
) |
|
|
|
||||
|
|
|
|
|
|
(7,941 |
) |
(10 |
) |
|
|
|
||||
Restructuring charges |
|
10,463 |
|
1.9 |
% |
|
|
(10,463 |
) |
(11 |
) |
|
— |
|
— |
% |
Operating income |
|
77,193 |
|
13.8 |
% |
|
|
15,483 |
|
|
|
92,676 |
|
16.6 |
% |
|
Non-operating income, net |
|
5 |
|
— |
% |
|
|
— |
|
|
|
5 |
|
— |
% |
|
Interest expense |
|
13,149 |
|
2.4 |
% |
|
|
— |
|
|
|
13,149 |
|
2.4 |
% |
|
Income before income tax |
|
64,049 |
|
11.5 |
% |
|
|
15,483 |
|
|
|
79,532 |
|
14.2 |
% |
|
Income tax expense |
|
12,223 |
|
2.2 |
% |
|
|
1,050 |
|
|
|
13,273 |
|
2.4 |
% |
|
Net income |
$ |
51,826 |
|
9.3 |
% |
|
$ |
14,433 |
|
|
$ |
66,259 |
|
11.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS |
$ |
2.15 |
|
|
|
$ |
0.60 |
|
|
$ |
2.75 |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted average shares of common stock used in computing diluted EPS |
|
24,078 |
|
|
|
|
|
|
24,078 |
|
|
|||||
|
Three Months Ended |
|||||||||||||||
|
As Reported
|
|
Adjustments |
|
Adjusted
|
|||||||||||
Sales revenue, net |
$ |
624,884 |
|
100.0 |
% |
|
$ |
— |
|
|
$ |
624,884 |
|
100.0 |
% |
|
Cost of goods sold |
|
351,051 |
|
56.2 |
% |
|
|
(306 |
) |
(7 |
) |
|
350,745 |
|
56.1 |
% |
Gross profit |
|
273,833 |
|
43.8 |
% |
|
|
306 |
|
|
|
274,139 |
|
43.9 |
% |
|
SG&A |
|
183,788 |
|
29.4 |
% |
|
|
(4,620 |
) |
(7 |
) |
|
168,020 |
|
26.9 |
% |
|
|
|
|
|
|
(1,605 |
) |
(12 |
) |
|
|
|
||||
|
|
|
|
|
|
(2,994 |
) |
(9 |
) |
|
|
|
||||
|
|
|
|
|
|
(6,549 |
) |
(10 |
) |
|
|
|
||||
Restructuring charges |
|
5 |
|
— |
% |
|
|
(5 |
) |
(11 |
) |
|
— |
|
— |
% |
Operating income |
|
90,040 |
|
14.4 |
% |
|
|
16,079 |
|
|
|
106,119 |
|
17.0 |
% |
|
Non-operating income, net |
|
52 |
|
— |
% |
|
|
— |
|
|
|
52 |
|
— |
% |
|
Interest expense |
|
3,206 |
|
0.5 |
% |
|
|
— |
|
|
|
3,206 |
|
0.5 |
% |
|
Income before income tax |
|
86,886 |
|
13.9 |
% |
|
|
16,079 |
|
|
|
102,965 |
|
16.5 |
% |
|
Income tax expense |
|
11,203 |
|
1.8 |
% |
|
|
1,113 |
|
|
|
12,316 |
|
2.0 |
% |
|
Net income |
$ |
75,683 |
|
12.1 |
% |
|
$ |
14,966 |
|
|
$ |
90,649 |
|
14.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS |
$ |
3.10 |
|
|
|
$ |
0.61 |
|
|
$ |
3.72 |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted average shares of common stock used in computing diluted EPS |
|
24,399 |
|
|
|
|
|
|
24,399 |
|
|
|||||
Condensed Consolidated Statements of Income and Reconciliation of Non-GAAP Financial
|
||||||||||||||||
|
Nine Months Ended |
|||||||||||||||
|
As Reported
|
|
Adjustments |
|
Adjusted
|
|||||||||||
Sales revenue, net |
$ |
1,588,084 |
|
100.0 |
% |
|
$ |
— |
|
|
$ |
1,588,084 |
|
100.0 |
% |
|
Cost of goods sold |
|
898,791 |
|
56.6 |
% |
|
|
(16,928 |
) |
(7 |
) |
|
881,863 |
|
55.5 |
% |
Gross profit |
|
689,293 |
|
43.4 |
% |
|
|
16,928 |
|
|
|
706,221 |
|
44.5 |
% |
|
SG&A |
|
515,974 |
|
32.5 |
% |
|
|
(5,173 |
) |
(7 |
) |
|
471,976 |
|
29.7 |
% |
|
|
|
|
|
|
(2,784 |
) |
(12 |
) |
|
|
|
||||
|
|
|
|
|
|
9,676 |
|
(8 |
) |
|
|
|
||||
|
|
|
|
|
|
(13,662 |
) |
(9 |
) |
|
|
|
||||
|
|
|
|
|
|
(32,055 |
) |
(10 |
) |
|
|
|
||||
Restructuring charges |
|
15,241 |
|
1.0 |
% |
|
|
(15,241 |
) |
(11 |
) |
|
— |
|
— |
% |
Operating income |
|
158,078 |
|
10.0 |
% |
|
|
76,167 |
|
|
|
234,245 |
|
14.8 |
% |
|
Non-operating income, net |
|
185 |
|
— |
% |
|
|
— |
|
|
|
185 |
|
— |
% |
|
Interest expense |
|
26,688 |
|
1.7 |
% |
|
|
— |
|
|
|
26,688 |
|
1.7 |
% |
|
Income before income tax |
|
131,575 |
|
8.3 |
% |
|
|
76,167 |
|
|
|
207,742 |
|
13.1 |
% |
|
Income tax expense |
|
24,482 |
|
1.5 |
% |
|
|
4,114 |
|
|
|
28,596 |
|
1.8 |
% |
|
Net income |
$ |
107,093 |
|
6.7 |
% |
|
$ |
72,053 |
|
|
$ |
179,146 |
|
11.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS |
$ |
4.45 |
|
|
|
$ |
2.99 |
|
|
$ |
7.44 |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted average shares of common stock used in computing diluted EPS |
|
24,086 |
|
|
|
|
|
|
24,086 |
|
|
|||||
|
Nine Months Ended |
|||||||||||||||
|
As Reported
|
|
Adjustments |
|
Adjusted
|
|||||||||||
Sales revenue, net |
$ |
1,641,335 |
|
100.0 |
% |
|
$ |
— |
|
|
$ |
1,641,335 |
|
100.0 |
% |
|
Cost of goods sold |
|
936,322 |
|
57.0 |
% |
|
|
(13,775 |
) |
(7 |
) |
|
922,547 |
|
56.2 |
% |
Gross profit |
|
705,013 |
|
43.0 |
% |
|
|
13,775 |
|
|
|
718,788 |
|
43.8 |
% |
|
SG&A |
|
482,467 |
|
29.4 |
% |
|
|
(7,223 |
) |
(7 |
) |
|
436,327 |
|
26.6 |
% |
|
|
|
|
|
|
(1,605 |
) |
(12 |
) |
|
|
|
||||
|
|
|
|
|
|
(8,963 |
) |
(9 |
) |
|
|
|
||||
|
|
|
|
|
|
(28,349 |
) |
(10 |
) |
|
|
|
||||
Restructuring charges |
|
380 |
|
— |
% |
|
|
(380 |
) |
(11 |
) |
|
— |
|
— |
% |
Operating income |
|
222,166 |
|
13.5 |
% |
|
|
60,295 |
|
|
|
282,461 |
|
17.2 |
% |
|
Non-operating income, net |
|
185 |
|
— |
% |
|
|
— |
|
|
|
185 |
|
— |
% |
|
Interest expense |
|
9,508 |
|
0.6 |
% |
|
|
— |
|
|
|
9,508 |
|
0.6 |
% |
|
Income before income tax |
|
212,843 |
|
13.0 |
% |
|
|
60,295 |
|
|
|
273,138 |
|
16.6 |
% |
|
Income tax expense |
|
28,873 |
|
1.8 |
% |
|
|
3,337 |
|
|
|
32,210 |
|
2.0 |
% |
|
Net income |
$ |
183,970 |
|
11.2 |
% |
|
$ |
56,958 |
|
|
$ |
240,928 |
|
14.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS |
$ |
7.52 |
|
|
|
$ |
2.33 |
|
|
$ |
9.85 |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted average shares of common stock used in computing diluted EPS |
|
24,461 |
|
|
|
|
|
|
24,461 |
|
|
|||||
Consolidated and Segment Net Sales Revenue
|
|||||||||||||||
|
Three Months Ended |
||||||||||||||
|
Home & Outdoor |
|
Health & Wellness |
|
Beauty |
|
Total |
||||||||
Fiscal 2022 sales revenue, net |
$ |
246,135 |
|
|
$ |
203,900 |
|
|
$ |
174,849 |
|
|
$ |
624,884 |
|
Organic business (1) |
|
(57,262 |
) |
|
|
(22,046 |
) |
|
|
(36,242 |
) |
|
|
(115,550 |
) |
Impact of foreign currency |
|
(3,191 |
) |
|
|
(1,371 |
) |
|
|
(2,512 |
) |
|
|
(7,074 |
) |
Acquisition (2) |
|
43,255 |
|
|
|
— |
|
|
|
13,091 |
|
|
|
56,346 |
|
Change in sales revenue, net |
|
(17,198 |
) |
|
|
(23,417 |
) |
|
|
(25,663 |
) |
|
|
(66,278 |
) |
Fiscal 2023 sales revenue, net |
$ |
228,937 |
|
|
$ |
180,483 |
|
|
$ |
149,186 |
|
|
$ |
558,606 |
|
|
|
|
|
|
|
|
|
||||||||
Total net sales revenue growth (decline) |
|
(7.0 |
) % |
|
|
(11.5 |
) % |
|
|
(14.7 |
) % |
|
|
(10.6 |
) % |
Organic business |
|
(23.3 |
) % |
|
|
(10.8 |
) % |
|
|
(20.7 |
) % |
|
|
(18.5 |
) % |
Impact of foreign currency |
|
(1.3 |
) % |
|
|
(0.7 |
) % |
|
|
(1.4 |
) % |
|
|
(1.1 |
) % |
Acquisition |
|
17.6 |
% |
|
|
— |
% |
|
|
7.5 |
% |
|
|
9.0 |
% |
|
Nine Months Ended |
||||||||||||||
|
Home & Outdoor |
|
Health & Wellness |
|
Beauty |
|
Total |
||||||||
Fiscal 2022 sales revenue, net |
$ |
654,997 |
|
|
$ |
549,475 |
|
|
$ |
436,863 |
|
|
$ |
1,641,335 |
|
Organic business (1) |
|
(85,186 |
) |
|
|
(16,939 |
) |
|
|
(104,759 |
) |
|
|
(206,884 |
) |
Impact of foreign currency |
|
(7,950 |
) |
|
|
(2,606 |
) |
|
|
(4,253 |
) |
|
|
(14,809 |
) |
Acquisition (2) |
|
141,898 |
|
|
|
— |
|
|
|
26,544 |
|
|
|
168,442 |
|
Change in sales revenue, net |
|
48,762 |
|
|
|
(19,545 |
) |
|
|
(82,468 |
) |
|
|
(53,251 |
) |
Fiscal 2023 sales revenue, net |
$ |
703,759 |
|
|
$ |
529,930 |
|
|
$ |
354,395 |
|
|
$ |
1,588,084 |
|
|
|
|
|
|
|
|
|
||||||||
Total net sales revenue growth (decline) |
|
7.4 |
% |
|
|
(3.6 |
) % |
|
|
(18.9 |
) % |
|
|
(3.2 |
) % |
Organic business |
|
(13.0 |
) % |
|
|
(3.1 |
) % |
|
|
(24.0 |
) % |
|
|
(12.6 |
) % |
Impact of foreign currency |
|
(1.2 |
) % |
|
|
(0.5 |
) % |
|
|
(1.0 |
) % |
|
|
(0.9 |
) % |
Acquisition |
|
21.7 |
% |
|
|
— |
% |
|
|
6.1 |
% |
|
|
10.3 |
% |
Leadership Brand and Other Net Sales Revenue (2)
|
||||||||||||
|
Three Months Ended |
|||||||||||
|
2022 |
|
2021 |
|
$ Change |
|
% Change |
|||||
Leadership Brand sales revenue, net (4) |
$ |
451,500 |
|
$ |
506,982 |
|
$ |
(55,482 |
) |
|
(10.9 |
) % |
All other sales revenue, net |
|
107,106 |
|
|
117,902 |
|
|
(10,796 |
) |
|
(9.2 |
) % |
Total sales revenue, net |
$ |
558,606 |
|
$ |
624,884 |
|
$ |
(66,278 |
) |
|
(10.6 |
) % |
|
Nine Months Ended |
|||||||||||
|
2022 |
|
2021 |
|
$ Change |
|
% Change |
|||||
Leadership Brand sales revenue, net (4) |
$ |
1,338,849 |
|
$ |
1,329,858 |
|
$ |
8,991 |
|
|
0.7 |
% |
All other sales revenue, net |
|
249,235 |
|
|
311,477 |
|
|
(62,242 |
) |
|
(20.0 |
) % |
Total sales revenue, net |
$ |
1,588,084 |
|
$ |
1,641,335 |
|
$ |
(53,251 |
) |
|
(3.2 |
) % |
Consolidated and Segment |
|||||||||||||||
|
Three Months Ended |
||||||||||||||
|
Home & Outdoor |
|
Health & Wellness |
|
Beauty |
|
Total |
||||||||
Fiscal 2022 sales revenue, net |
$ |
246,135 |
|
|
$ |
203,900 |
|
|
$ |
174,849 |
|
|
$ |
624,884 |
|
Core business |
|
(17,198 |
) |
|
|
(23,417 |
) |
|
|
(21,288 |
) |
|
|
(61,903 |
) |
Non-Core business (Personal Care) |
|
— |
|
|
|
— |
|
|
|
(4,375 |
) |
|
|
(4,375 |
) |
Change in sales revenue, net |
|
(17,198 |
) |
|
|
(23,417 |
) |
|
|
(25,663 |
) |
|
|
(66,278 |
) |
Fiscal 2023 sales revenue, net |
$ |
228,937 |
|
|
$ |
180,483 |
|
|
$ |
149,186 |
|
|
$ |
558,606 |
|
|
|
|
|
|
|
|
|
||||||||
Total net sales revenue decline |
|
(7.0 |
) % |
|
|
(11.5 |
) % |
|
|
(14.7 |
) % |
|
|
(10.6 |
) % |
Core business |
|
(7.0 |
) % |
|
|
(11.5 |
) % |
|
|
(12.2 |
) % |
|
|
(9.9 |
) % |
Non-Core business (Personal Care) |
|
— |
% |
|
|
— |
% |
|
|
(2.5 |
) % |
|
|
(0.7 |
) % |
|
Nine Months Ended |
||||||||||||||
|
Home & Outdoor |
|
Health & Wellness |
|
Beauty |
|
Total |
||||||||
Fiscal 2022 sales revenue, net |
$ |
654,997 |
|
|
$ |
549,475 |
|
|
$ |
436,863 |
|
|
$ |
1,641,335 |
|
Core business |
|
48,762 |
|
|
|
(19,545 |
) |
|
|
(52,231 |
) |
|
|
(23,014 |
) |
Non-Core business (Personal Care) |
|
— |
|
|
|
— |
|
|
|
(30,237 |
) |
|
|
(30,237 |
) |
Change in sales revenue, net |
|
48,762 |
|
|
|
(19,545 |
) |
|
|
(82,468 |
) |
|
|
(53,251 |
) |
Fiscal 2023 sales revenue, net |
$ |
703,759 |
|
|
$ |
529,930 |
|
|
$ |
354,395 |
|
|
$ |
1,588,084 |
|
|
|
|
|
|
|
|
|
||||||||
Total net sales revenue growth (decline) |
|
7.4 |
% |
|
|
(3.6 |
) % |
|
|
(18.9 |
) % |
|
|
(3.2 |
) % |
Core business |
|
7.4 |
% |
|
|
(3.6 |
) % |
|
|
(12.0 |
) % |
|
|
(1.4 |
) % |
Non-Core business (Personal Care) |
|
— |
% |
|
|
— |
% |
|
|
(6.9 |
) % |
|
|
(1.8 |
) % |
Consolidated |
|||||||||||
|
Three Months Ended |
||||||||||
|
2022 |
|
2021 |
||||||||
|
$ |
410,832 |
|
73.5 |
% |
|
$ |
496,666 |
|
79.5 |
% |
International sales revenue, net |
|
147,774 |
|
26.5 |
% |
|
|
128,218 |
|
20.5 |
% |
Total sales revenue, net |
$ |
558,606 |
|
100.0 |
% |
|
$ |
624,884 |
|
100.0 |
% |
|
Nine Months Ended |
||||||||||
|
2022 |
|
2021 |
||||||||
|
$ |
1,170,349 |
|
73.7 |
% |
|
$ |
1,271,102 |
|
77.4 |
% |
International sales revenue, net |
|
417,735 |
|
26.3 |
% |
|
|
370,233 |
|
22.6 |
% |
Total sales revenue, net |
$ |
1,588,084 |
|
100.0 |
% |
|
$ |
1,641,335 |
|
100.0 |
% |
Reconciliation of Non-GAAP Financial Measures – GAAP Operating Income and Operating Margin
|
|||||||||||||||||||||||||||
|
Three Months Ended |
||||||||||||||||||||||||||
|
Home &
|
|
Health &
|
|
Beauty (2) |
|
Total |
||||||||||||||||||||
Operating income, as reported (GAAP) |
$ |
30,847 |
|
|
13.5 |
% |
|
$ |
21,257 |
|
|
11.8 |
% |
|
$ |
25,089 |
|
|
16.8 |
% |
|
$ |
77,193 |
|
|
13.8 |
% |
Acquisition-related expenses |
|
(2 |
) |
|
— |
% |
|
|
— |
|
|
— |
% |
|
|
2 |
|
|
— |
% |
|
|
— |
|
|
— |
% |
|
|
— |
|
|
— |
% |
|
|
2,103 |
|
|
1.2 |
% |
|
|
— |
|
|
— |
% |
|
|
2,103 |
|
|
0.4 |
% |
Gain from insurance recoveries |
|
— |
|
|
— |
% |
|
|
(8,167 |
) |
|
(4.5 |
) % |
|
|
(1,509 |
) |
|
(1.0 |
) % |
|
|
(9,676 |
) |
|
(1.7 |
) % |
Restructuring charges |
|
5,090 |
|
|
2.2 |
% |
|
|
2,893 |
|
|
1.6 |
% |
|
|
2,480 |
|
|
1.7 |
% |
|
|
10,463 |
|
|
1.9 |
% |
Subtotal |
|
35,935 |
|
|
15.7 |
% |
|
|
18,086 |
|
|
10.0 |
% |
|
|
26,062 |
|
|
17.5 |
% |
|
|
80,083 |
|
|
14.3 |
% |
Amortization of intangible assets |
|
1,756 |
|
|
0.8 |
% |
|
|
582 |
|
|
0.3 |
% |
|
|
2,314 |
|
|
1.6 |
% |
|
|
4,652 |
|
|
0.8 |
% |
Non-cash share-based compensation |
|
2,169 |
|
|
0.9 |
% |
|
|
2,665 |
|
|
1.5 |
% |
|
|
3,107 |
|
|
2.1 |
% |
|
|
7,941 |
|
|
1.4 |
% |
Adjusted operating income (non-GAAP) |
$ |
39,860 |
|
|
17.4 |
% |
|
$ |
21,333 |
|
|
11.8 |
% |
|
$ |
31,483 |
|
|
21.1 |
% |
|
$ |
92,676 |
|
|
16.6 |
% |
|
Three Months Ended |
||||||||||||||||||||||
|
Home &
|
|
Health &
|
|
Beauty |
|
Total |
||||||||||||||||
Operating income, as reported (GAAP) |
$ |
43,239 |
|
17.6 |
% |
|
$ |
13,573 |
|
6.7 |
% |
|
$ |
33,228 |
|
19.0 |
% |
|
$ |
90,040 |
|
14.4 |
% |
Acquisition-related expenses |
|
1,605 |
|
0.7 |
% |
|
|
— |
|
— |
% |
|
|
— |
|
— |
% |
|
|
1,605 |
|
0.3 |
% |
|
|
— |
|
— |
% |
|
|
4,926 |
|
2.4 |
% |
|
|
— |
|
— |
% |
|
|
4,926 |
|
0.8 |
% |
Restructuring charges |
|
— |
|
— |
% |
|
|
— |
|
— |
% |
|
|
5 |
|
— |
% |
|
|
5 |
|
— |
% |
Subtotal |
|
44,844 |
|
18.2 |
% |
|
|
18,499 |
|
9.1 |
% |
|
|
33,233 |
|
19.0 |
% |
|
|
96,576 |
|
15.5 |
% |
Amortization of intangible assets |
|
525 |
|
0.2 |
% |
|
|
572 |
|
0.3 |
% |
|
|
1,897 |
|
1.1 |
% |
|
|
2,994 |
|
0.5 |
% |
Non-cash share-based compensation |
|
2,339 |
|
1.0 |
% |
|
|
2,717 |
|
1.3 |
% |
|
|
1,493 |
|
0.9 |
% |
|
|
6,549 |
|
1.0 |
% |
Adjusted operating income (non-GAAP) |
$ |
47,708 |
|
19.4 |
% |
|
$ |
21,788 |
|
10.7 |
% |
|
$ |
36,623 |
|
20.9 |
% |
|
$ |
106,119 |
|
17.0 |
% |
|
Nine Months Ended |
|||||||||||||||||||||||||
|
Home &
|
|
Health &
|
|
Beauty (2) |
|
Total |
|||||||||||||||||||
Operating income, as reported (GAAP) |
$ |
102,722 |
|
14.6 |
% |
|
$ |
12,505 |
|
|
2.4 |
% |
|
$ |
42,851 |
|
|
12.1 |
% |
|
$ |
158,078 |
|
|
10.0 |
% |
Acquisition-related expenses |
|
117 |
|
— |
% |
|
|
— |
|
|
— |
% |
|
|
2,667 |
|
|
0.8 |
% |
|
|
2,784 |
|
|
0.2 |
% |
|
|
— |
|
— |
% |
|
|
22,101 |
|
|
4.2 |
% |
|
|
— |
|
|
— |
% |
|
|
22,101 |
|
|
1.4 |
% |
Gain from insurance recoveries |
|
— |
|
— |
% |
|
|
(8,167 |
) |
|
(1.5 |
) % |
|
|
(1,509 |
) |
|
(0.4 |
) % |
|
|
(9,676 |
) |
|
(0.6 |
) % |
Restructuring charges |
|
5,562 |
|
0.8 |
% |
|
|
6,447 |
|
|
1.2 |
% |
|
|
3,232 |
|
|
0.9 |
% |
|
|
15,241 |
|
|
1.0 |
% |
Subtotal |
|
108,401 |
|
15.4 |
% |
|
|
32,886 |
|
|
6.2 |
% |
|
|
47,241 |
|
|
13.3 |
% |
|
|
188,528 |
|
|
11.9 |
% |
Amortization of intangible assets |
|
5,255 |
|
0.7 |
% |
|
|
1,743 |
|
|
0.3 |
% |
|
|
6,664 |
|
|
1.9 |
% |
|
|
13,662 |
|
|
0.9 |
% |
Non-cash share-based compensation |
|
10,807 |
|
1.5 |
% |
|
|
11,078 |
|
|
2.1 |
% |
|
|
10,170 |
|
|
2.9 |
% |
|
|
32,055 |
|
|
2.0 |
% |
Adjusted operating income (non-GAAP) |
$ |
124,463 |
|
17.7 |
% |
|
$ |
45,707 |
|
|
8.6 |
% |
|
$ |
64,075 |
|
|
18.1 |
% |
|
$ |
234,245 |
|
|
14.8 |
% |
|
Nine Months Ended |
||||||||||||||||||||||
|
Home &
|
|
Health &
|
|
Beauty |
|
Total |
||||||||||||||||
Operating income, as reported (GAAP) |
$ |
112,303 |
|
17.1 |
% |
|
$ |
29,616 |
|
5.4 |
% |
|
$ |
80,247 |
|
18.4 |
% |
|
$ |
222,166 |
|
13.5 |
% |
Acquisition-related expenses |
|
1,605 |
|
0.2 |
% |
|
|
— |
|
— |
% |
|
|
— |
|
— |
% |
|
|
1,605 |
|
0.1 |
% |
|
|
— |
|
— |
% |
|
|
20,998 |
|
3.8 |
% |
|
|
— |
|
— |
% |
|
|
20,998 |
|
1.3 |
% |
Restructuring charges |
|
369 |
|
0.1 |
% |
|
|
— |
|
— |
% |
|
|
11 |
|
— |
% |
|
|
380 |
|
— |
% |
Subtotal |
|
114,277 |
|
17.4 |
% |
|
|
50,614 |
|
9.2 |
% |
|
|
80,258 |
|
18.4 |
% |
|
|
245,149 |
|
14.9 |
% |
Amortization of intangible assets |
|
1,562 |
|
0.2 |
% |
|
|
1,709 |
|
0.3 |
% |
|
|
5,692 |
|
1.3 |
% |
|
|
8,963 |
|
0.5 |
% |
Non-cash share-based compensation |
|
11,047 |
|
1.7 |
% |
|
|
10,229 |
|
1.9 |
% |
|
|
7,073 |
|
1.6 |
% |
|
|
28,349 |
|
1.7 |
% |
Adjusted operating income (non-GAAP) |
$ |
126,886 |
|
19.4 |
% |
|
$ |
62,552 |
|
11.4 |
% |
|
$ |
93,023 |
|
21.3 |
% |
|
$ |
282,461 |
|
17.2 |
% |
Reconciliation of Non-GAAP Financial Measures - EBITDA
|
|||||||||||||||
|
Three Months Ended |
||||||||||||||
|
Home &
|
|
Health &
|
|
Beauty (2) |
|
Total |
||||||||
Operating income, as reported (GAAP) |
$ |
30,847 |
|
|
$ |
21,257 |
|
|
$ |
25,089 |
|
|
$ |
77,193 |
|
Depreciation and amortization |
|
4,716 |
|
|
|
3,446 |
|
|
|
3,551 |
|
|
|
11,713 |
|
Non-operating income, net |
|
— |
|
|
|
— |
|
|
|
5 |
|
|
|
5 |
|
EBITDA (non-GAAP) |
|
35,563 |
|
|
|
24,703 |
|
|
|
28,645 |
|
|
|
88,911 |
|
Add: Acquisition-related expenses |
|
(2 |
) |
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
2,103 |
|
|
|
— |
|
|
|
2,103 |
|
Gain from insurance recoveries |
|
— |
|
|
|
(8,167 |
) |
|
|
(1,509 |
) |
|
|
(9,676 |
) |
Restructuring charges |
|
5,090 |
|
|
|
2,893 |
|
|
|
2,480 |
|
|
|
10,463 |
|
Non-cash share-based compensation |
|
2,169 |
|
|
|
2,665 |
|
|
|
3,107 |
|
|
|
7,941 |
|
Adjusted EBITDA (non-GAAP) |
$ |
42,820 |
|
|
$ |
24,197 |
|
|
$ |
32,725 |
|
|
$ |
99,742 |
|
|
Three Months Ended |
||||||||||
|
Home &
|
|
Health &
|
|
Beauty |
|
Total |
||||
Operating income, as reported (GAAP) |
$ |
43,239 |
|
$ |
13,573 |
|
$ |
33,228 |
|
$ |
90,040 |
Depreciation and amortization |
|
2,894 |
|
|
2,529 |
|
|
3,218 |
|
|
8,641 |
Non-operating income, net |
|
— |
|
|
— |
|
|
52 |
|
|
52 |
EBITDA (non-GAAP) |
|
46,133 |
|
|
16,102 |
|
|
36,498 |
|
|
98,733 |
Add: Acquisition-related expenses |
|
1,605 |
|
|
— |
|
|
— |
|
|
1,605 |
|
|
— |
|
|
4,926 |
|
|
— |
|
|
4,926 |
Restructuring charges |
|
— |
|
|
— |
|
|
5 |
|
|
5 |
Non-cash share-based compensation |
|
2,339 |
|
|
2,717 |
|
|
1,493 |
|
|
6,549 |
Adjusted EBITDA (non-GAAP) |
$ |
50,077 |
|
$ |
23,745 |
|
$ |
37,996 |
|
$ |
111,818 |
|
Nine Months Ended |
|||||||||||||
|
Home &
|
|
Health &
|
|
Beauty (2) |
|
Total |
|||||||
Operating income, as reported (GAAP) |
$ |
102,722 |
|
$ |
12,505 |
|
|
$ |
42,851 |
|
|
$ |
158,078 |
|
Depreciation and amortization |
|
13,704 |
|
|
9,279 |
|
|
|
10,347 |
|
|
|
33,330 |
|
Non-operating income, net |
|
— |
|
|
— |
|
|
|
185 |
|
|
|
185 |
|
EBITDA (non-GAAP) |
|
116,426 |
|
|
21,784 |
|
|
|
53,383 |
|
|
|
191,593 |
|
Add: Acquisition-related expenses |
|
117 |
|
|
— |
|
|
|
2,667 |
|
|
|
2,784 |
|
|
|
— |
|
|
22,101 |
|
|
|
— |
|
|
|
22,101 |
|
Gain from insurance recoveries |
|
— |
|
|
(8,167 |
) |
|
|
(1,509 |
) |
|
|
(9,676 |
) |
Restructuring charges |
|
5,562 |
|
|
6,447 |
|
|
|
3,232 |
|
|
|
15,241 |
|
Non-cash share-based compensation |
|
10,807 |
|
|
11,078 |
|
|
|
10,170 |
|
|
|
32,055 |
|
Adjusted EBITDA (non-GAAP) |
$ |
132,912 |
|
$ |
53,243 |
|
|
$ |
67,943 |
|
|
$ |
254,098 |
|
Reconciliation of Non-GAAP Financial Measures - EBITDA
|
|||||||||||
|
Nine Months Ended |
||||||||||
|
Home &
|
|
Health &
|
|
Beauty |
|
Total |
||||
Operating income, as reported (GAAP) |
$ |
112,303 |
|
$ |
29,616 |
|
$ |
80,247 |
|
$ |
222,166 |
Depreciation and amortization |
|
8,257 |
|
|
7,879 |
|
|
9,946 |
|
|
26,082 |
Non-operating income, net |
|
— |
|
|
— |
|
|
185 |
|
|
185 |
EBITDA (non-GAAP) |
|
120,560 |
|
|
37,495 |
|
|
90,378 |
|
|
248,433 |
Add: Acquisition-related expenses |
|
1,605 |
|
|
— |
|
|
— |
|
|
1,605 |
|
|
— |
|
|
20,998 |
|
|
— |
|
|
20,998 |
Restructuring charges |
|
369 |
|
|
— |
|
|
11 |
|
|
380 |
Non-cash share-based compensation |
|
11,047 |
|
|
10,229 |
|
|
7,073 |
|
|
28,349 |
Adjusted EBITDA (non-GAAP) |
$ |
133,581 |
|
$ |
68,722 |
|
$ |
97,462 |
|
$ |
299,765 |
Reconciliation of Non-GAAP Financial Measures – GAAP Income and Diluted EPS to
|
|||||||||||||||||||||||
|
Three Months Ended |
||||||||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||||||||
As reported (GAAP) |
$ |
64,049 |
|
|
$ |
12,223 |
|
|
$ |
51,826 |
|
|
$ |
2.66 |
|
|
$ |
0.51 |
|
|
$ |
2.15 |
|
Acquisition-related expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,103 |
|
|
|
32 |
|
|
|
2,071 |
|
|
|
0.09 |
|
|
|
— |
|
|
|
0.09 |
|
Gain from insurance recoveries |
|
(9,676 |
) |
|
|
(121 |
) |
|
|
(9,555 |
) |
|
|
(0.40 |
) |
|
|
(0.01 |
) |
|
|
(0.40 |
) |
Restructuring charges |
|
10,463 |
|
|
|
131 |
|
|
|
10,332 |
|
|
|
0.43 |
|
|
|
0.01 |
|
|
|
0.43 |
|
Subtotal |
|
66,939 |
|
|
|
12,265 |
|
|
|
54,674 |
|
|
|
2.78 |
|
|
|
0.51 |
|
|
|
2.27 |
|
Amortization of intangible assets |
|
4,652 |
|
|
|
534 |
|
|
|
4,118 |
|
|
|
0.19 |
|
|
|
0.02 |
|
|
|
0.17 |
|
Non-cash share-based compensation |
|
7,941 |
|
|
|
474 |
|
|
|
7,467 |
|
|
|
0.33 |
|
|
|
0.02 |
|
|
|
0.31 |
|
Adjusted (non-GAAP) |
$ |
79,532 |
|
|
$ |
13,273 |
|
|
$ |
66,259 |
|
|
$ |
3.30 |
|
|
$ |
0.55 |
|
|
$ |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
24,078 |
|
|||||||||||||||||||
|
Three Months Ended |
||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||
As reported (GAAP) |
$ |
86,886 |
|
$ |
11,203 |
|
$ |
75,683 |
|
$ |
3.56 |
|
$ |
0.46 |
|
$ |
3.10 |
Acquisition-related expenses |
|
1,605 |
|
|
58 |
|
|
1,547 |
|
|
0.07 |
|
|
— |
|
|
0.06 |
|
|
4,926 |
|
|
74 |
|
|
4,852 |
|
|
0.20 |
|
|
— |
|
|
0.20 |
Restructuring charges |
|
5 |
|
|
— |
|
|
5 |
|
|
— |
|
|
— |
|
|
— |
Subtotal |
|
93,422 |
|
|
11,335 |
|
|
82,087 |
|
|
3.83 |
|
|
0.46 |
|
|
3.36 |
Amortization of intangible assets |
|
2,994 |
|
|
197 |
|
|
2,797 |
|
|
0.12 |
|
|
0.01 |
|
|
0.11 |
Non-cash share-based compensation |
|
6,549 |
|
|
784 |
|
|
5,765 |
|
|
0.27 |
|
|
0.03 |
|
|
0.24 |
Adjusted (non-GAAP) |
$ |
102,965 |
|
$ |
12,316 |
|
$ |
90,649 |
|
$ |
4.22 |
|
$ |
0.50 |
|
$ |
3.72 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
24,399 |
||||||||||||||
|
Three Months Ended |
||||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||||
As reported (GAAP) |
$ |
97,876 |
|
|
$ |
13,721 |
|
$ |
84,155 |
|
|
$ |
3.89 |
|
$ |
0.55 |
|
$ |
3.34 |
Restructuring charges |
|
(12 |
) |
|
|
— |
|
|
(12 |
) |
|
|
— |
|
|
— |
|
|
— |
Subtotal |
|
97,864 |
|
|
|
13,721 |
|
|
84,143 |
|
|
|
3.89 |
|
|
0.55 |
|
|
3.34 |
Amortization of intangible assets |
|
4,501 |
|
|
|
204 |
|
|
4,297 |
|
|
|
0.18 |
|
|
0.01 |
|
|
0.17 |
Non-cash share-based compensation |
|
6,739 |
|
|
|
403 |
|
|
6,336 |
|
|
|
0.27 |
|
|
0.02 |
|
|
0.25 |
Adjusted (non-GAAP) |
$ |
109,104 |
|
|
$ |
14,328 |
|
$ |
94,776 |
|
|
$ |
4.33 |
|
$ |
0.57 |
|
$ |
3.76 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
25,192 |
||||||||||||||||
Reconciliation of Non-GAAP Financial Measures – GAAP Income and Diluted EPS to
|
|||||||||||||||||
|
Three Months Ended |
||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||
As reported (GAAP) |
$ |
76,594 |
|
$ |
7,895 |
|
$ |
68,699 |
|
$ |
3.02 |
|
$ |
0.31 |
|
$ |
2.71 |
Acquisition-related expenses |
|
1,475 |
|
|
22 |
|
|
1,453 |
|
|
0.06 |
|
|
— |
|
|
0.06 |
Restructuring charges |
|
12 |
|
|
— |
|
|
12 |
|
|
— |
|
|
— |
|
|
— |
Subtotal |
|
78,081 |
|
|
7,917 |
|
|
70,164 |
|
|
3.07 |
|
|
0.31 |
|
|
2.76 |
Amortization of intangible assets |
|
4,790 |
|
|
252 |
|
|
4,538 |
|
|
0.19 |
|
|
0.01 |
|
|
0.18 |
Non-cash share-based compensation |
|
4,758 |
|
|
343 |
|
|
4,415 |
|
|
0.19 |
|
|
0.01 |
|
|
0.17 |
Adjusted (non-GAAP) |
$ |
87,629 |
|
$ |
8,512 |
|
$ |
79,117 |
|
$ |
3.45 |
|
$ |
0.34 |
|
$ |
3.12 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
25,396 |
||||||||||||||
Reconciliation of Non-GAAP Financial Measures – GAAP Income and Diluted EPS to
|
|||||||||||||||||||||||
|
Nine Months Ended |
||||||||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||||||||
As reported (GAAP) |
$ |
131,575 |
|
|
$ |
24,482 |
|
|
$ |
107,093 |
|
|
$ |
5.46 |
|
|
$ |
1.02 |
|
|
$ |
4.45 |
|
Acquisition-related expenses |
|
2,784 |
|
|
|
2 |
|
|
|
2,782 |
|
|
|
0.12 |
|
|
|
— |
|
|
|
0.12 |
|
|
|
22,101 |
|
|
|
332 |
|
|
|
21,769 |
|
|
|
0.92 |
|
|
|
0.01 |
|
|
|
0.90 |
|
Gain from insurance recoveries |
|
(9,676 |
) |
|
|
(121 |
) |
|
|
(9,555 |
) |
|
|
(0.40 |
) |
|
|
(0.01 |
) |
|
|
(0.40 |
) |
Restructuring charges |
|
15,241 |
|
|
|
192 |
|
|
|
15,049 |
|
|
|
0.63 |
|
|
|
0.01 |
|
|
|
0.62 |
|
Subtotal |
|
162,025 |
|
|
|
24,887 |
|
|
|
137,138 |
|
|
|
6.73 |
|
|
|
1.03 |
|
|
|
5.69 |
|
Amortization of intangible assets |
|
13,662 |
|
|
|
1,581 |
|
|
|
12,081 |
|
|
|
0.57 |
|
|
|
0.07 |
|
|
|
0.50 |
|
Non-cash share-based compensation |
|
32,055 |
|
|
|
2,128 |
|
|
|
29,927 |
|
|
|
1.33 |
|
|
|
0.09 |
|
|
|
1.24 |
|
Adjusted (non-GAAP) |
$ |
207,742 |
|
|
$ |
28,596 |
|
|
$ |
179,146 |
|
|
$ |
8.63 |
|
|
$ |
1.19 |
|
|
$ |
7.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
24,086 |
|
|||||||||||||||||||
|
Nine Months Ended |
||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||
As reported (GAAP) |
$ |
212,843 |
|
$ |
28,873 |
|
$ |
183,970 |
|
$ |
8.70 |
|
$ |
1.18 |
|
$ |
7.52 |
Acquisition-related expenses |
|
1,605 |
|
|
58 |
|
|
1,547 |
|
|
0.07 |
|
|
— |
|
|
0.06 |
|
|
20,998 |
|
|
315 |
|
|
20,683 |
|
|
0.86 |
|
|
0.01 |
|
|
0.85 |
Restructuring charges |
|
380 |
|
|
6 |
|
|
374 |
|
|
0.02 |
|
|
— |
|
|
0.02 |
Subtotal |
|
235,826 |
|
|
29,252 |
|
|
206,574 |
|
|
9.64 |
|
|
1.20 |
|
|
8.45 |
Amortization of intangible assets |
|
8,963 |
|
|
603 |
|
|
8,360 |
|
|
0.37 |
|
|
0.02 |
|
|
0.34 |
Non-cash share-based compensation |
|
28,349 |
|
|
2,355 |
|
|
25,994 |
|
|
1.16 |
|
|
0.10 |
|
|
1.06 |
Adjusted (non-GAAP) |
$ |
273,138 |
|
$ |
32,210 |
|
$ |
240,928 |
|
$ |
11.17 |
|
$ |
1.32 |
|
$ |
9.85 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
24,461 |
||||||||||||||
|
Nine Months Ended |
||||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||||
As reported (GAAP) |
$ |
247,835 |
|
$ |
16,061 |
|
$ |
231,774 |
|
|
$ |
9.78 |
|
$ |
0.63 |
|
$ |
9.14 |
|
Restructuring charges |
|
355 |
|
|
2 |
|
|
353 |
|
|
|
0.01 |
|
|
— |
|
|
0.01 |
|
Tax reform |
|
— |
|
|
9,357 |
|
|
(9,357 |
) |
|
|
— |
|
|
0.37 |
|
|
(0.37 |
) |
Subtotal |
|
248,190 |
|
|
25,420 |
|
|
222,770 |
|
|
|
9.79 |
|
|
1.00 |
|
|
8.79 |
|
Amortization of intangible assets |
|
13,527 |
|
|
651 |
|
|
12,876 |
|
|
|
0.53 |
|
|
0.03 |
|
|
0.51 |
|
Non-cash share-based compensation |
|
20,654 |
|
|
1,406 |
|
|
19,248 |
|
|
|
0.82 |
|
|
0.06 |
|
|
0.76 |
|
Adjusted (non-GAAP) |
$ |
282,371 |
|
$ |
27,477 |
|
$ |
254,894 |
|
|
$ |
11.14 |
|
$ |
1.08 |
|
$ |
10.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
25,350 |
|
|||||||||||||||
Reconciliation of Non-GAAP Financial Measures – GAAP Income and Diluted EPS to
|
|||||||||||||||||
|
Nine Months Ended |
||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||
As reported (GAAP) |
$ |
172,018 |
|
$ |
16,530 |
|
$ |
155,488 |
|
$ |
6.80 |
|
$ |
0.65 |
|
$ |
6.15 |
Acquisition-related expenses |
|
1,475 |
|
|
22 |
|
|
1,453 |
|
|
0.06 |
|
|
— |
|
|
0.06 |
Restructuring charges |
|
1,061 |
|
|
68 |
|
|
993 |
|
|
0.04 |
|
|
— |
|
|
0.04 |
Subtotal |
|
174,554 |
|
|
16,620 |
|
|
157,934 |
|
|
6.90 |
|
|
0.66 |
|
|
6.24 |
Amortization of intangible assets |
|
13,129 |
|
|
621 |
|
|
12,508 |
|
|
0.52 |
|
|
0.02 |
|
|
0.49 |
Non-cash share-based compensation |
|
18,743 |
|
|
1,434 |
|
|
17,309 |
|
|
0.74 |
|
|
0.06 |
|
|
0.68 |
Adjusted (non-GAAP) |
$ |
206,426 |
|
$ |
18,675 |
|
$ |
187,751 |
|
$ |
8.16 |
|
$ |
0.74 |
|
$ |
7.42 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
25,295 |
||||||||||||||
Consolidated Core and Non-Core |
||||||||||||
|
Three Months Ended |
|||||||||||
|
2022 |
|
2021 |
|
$ Change |
|
% Change |
|||||
Sales revenue, net |
|
|
|
|
|
|
|
|||||
Core |
$ |
558,606 |
|
$ |
620,509 |
|
$ |
(61,903 |
) |
|
(10.0 |
) % |
Non-Core |
|
— |
|
|
4,375 |
|
|
(4,375 |
) |
|
(100.0 |
) % |
Total |
$ |
558,606 |
|
$ |
624,884 |
|
$ |
(66,278 |
) |
|
(10.6 |
) % |
|
Three Months Ended |
|||||||||||
|
2022 |
|
2021 |
|
$ Change |
|
% Change |
|||||
Adjusted Diluted EPS (non-GAAP) |
|
|
|
|
|
|
|
|||||
Core |
$ |
2.75 |
|
$ |
3.72 |
|
$ |
(0.97 |
) |
|
(26.1 |
) % |
Non-Core |
|
— |
|
|
— |
|
|
— |
|
|
— |
% |
Total |
$ |
2.75 |
|
$ |
3.72 |
|
$ |
(0.97 |
) |
|
(26.1 |
) % |
|
Three Months Ended |
||||||
Core Business: |
2022 |
|
2021 |
||||
Diluted EPS, as reported |
$ |
2.15 |
|
|
$ |
3.10 |
|
Acquisition-related expenses, net of tax |
|
— |
|
|
|
0.06 |
|
|
|
0.09 |
|
|
|
0.20 |
|
Gain from insurance recoveries |
|
(0.40 |
) |
|
|
— |
|
Restructuring charges, net of tax |
|
0.43 |
|
|
|
— |
|
Subtotal |
|
2.27 |
|
|
|
3.36 |
|
Amortization of intangible assets, net of tax |
|
0.17 |
|
|
|
0.11 |
|
Non-cash share-based compensation, net of tax |
|
0.31 |
|
|
|
0.24 |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
2.75 |
|
|
$ |
3.72 |
|
|
|||||||
|
Three Months Ended |
||||||
Non-Core Business: |
2022 |
|
2021 |
||||
Diluted EPS, as reported |
$ |
— |
|
|
$ |
— |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
— |
|
|
$ |
— |
|
|
|
|
|
||||
Diluted EPS, as reported (GAAP) |
$ |
2.15 |
|
|
$ |
3.10 |
|
Consolidated Core and Non-Core |
|||||
|
Three Months Ended |
||||
|
2020 |
|
2019 |
||
Sales revenue, net |
|
|
|
||
Core |
$ |
617,766 |
|
$ |
450,742 |
Non-Core |
|
19,971 |
|
|
23,995 |
Total |
$ |
637,737 |
|
$ |
474,737 |
|
Three Months Ended |
||||
|
2020 |
|
2019 |
||
Adjusted Diluted EPS (non-GAAP) |
|
|
|
||
Core |
$ |
3.61 |
|
$ |
2.98 |
Non-Core |
|
0.15 |
|
|
0.14 |
Total |
$ |
3.76 |
|
$ |
3.12 |
|
Three Months Ended |
|||||
Core Business: |
2020 |
|
2019 |
|||
Diluted EPS, as reported |
$ |
3.19 |
|
$ |
2.62 |
|
Acquisition-related expenses, net of tax |
|
— |
|
|
0.06 |
|
Subtotal |
|
3.19 |
|
|
2.68 |
|
Amortization of intangible assets, net of tax |
|
0.17 |
|
|
0.13 |
|
Non-cash share-based compensation, net of tax |
|
0.25 |
|
|
0.17 |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
3.61 |
|
$ |
2.98 |
|
|
||||||
|
Three Months Ended |
|||||
Non-Core Business: |
2020 |
|
2019 |
|||
Diluted EPS, as reported |
$ |
0.15 |
|
$ |
0.09 |
|
Amortization of intangible assets, net of tax |
|
— |
|
|
0.05 |
|
Non-cash share-based compensation, net of tax |
|
— |
|
|
— |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
0.15 |
|
$ |
0.14 |
|
|
|
|
|
|||
Diluted EPS, as reported (GAAP) |
$ |
3.34 |
|
$ |
2.71 |
|
Consolidated Core and Non-Core |
||||||||||||
|
Nine Months Ended |
|||||||||||
|
2022 |
|
2021 |
|
$ Change |
|
% Change |
|||||
Sales revenue, net |
|
|
|
|
|
|
|
|||||
Core |
$ |
1,588,084 |
|
$ |
1,611,098 |
|
$ |
(23,014 |
) |
|
(1.4 |
) % |
Non-Core |
|
— |
|
|
30,237 |
|
|
(30,237 |
) |
|
(100.0 |
) % |
Total |
$ |
1,588,084 |
|
$ |
1,641,335 |
|
$ |
(53,251 |
) |
|
(3.2 |
) % |
|
Nine Months Ended |
|||||||||||
|
2022 |
|
2021 |
|
$ Change |
|
% Change |
|||||
Adjusted Diluted EPS (non-GAAP) |
|
|
|
|
|
|
|
|||||
Core |
$ |
7.44 |
|
$ |
9.67 |
|
$ |
(2.23 |
) |
|
(23.1 |
) % |
Non-Core |
|
— |
|
|
0.18 |
|
|
(0.18 |
) |
|
(100.0 |
) % |
Total |
$ |
7.44 |
|
$ |
9.85 |
|
$ |
(2.41 |
) |
|
(24.5 |
) % |
|
Nine Months Ended |
||||||
Core Business: |
2022 |
|
2021 |
||||
Diluted EPS, as reported |
$ |
4.45 |
|
|
$ |
7.35 |
|
Acquisition-related expenses, net of tax |
|
0.12 |
|
|
|
0.06 |
|
|
|
0.90 |
|
|
|
0.85 |
|
Gain from insurance recoveries |
|
(0.40 |
) |
|
|
— |
|
Restructuring charges, net of tax |
|
0.62 |
|
|
|
0.02 |
|
Subtotal |
|
5.69 |
|
|
|
8.28 |
|
Amortization of intangible assets, net of tax |
|
0.50 |
|
|
|
0.34 |
|
Non-cash share-based compensation, net of tax |
|
1.24 |
|
|
|
1.05 |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
7.44 |
|
|
$ |
9.67 |
|
|
|||||||
|
Nine Months Ended |
||||||
Non-Core Business: |
2022 |
|
2021 |
||||
Diluted EPS, as reported |
$ |
— |
|
|
$ |
0.17 |
|
Non-cash share-based compensation, net of tax |
|
— |
|
|
|
0.01 |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
— |
|
|
$ |
0.18 |
|
|
|
|
|
||||
Diluted EPS, as reported (GAAP) |
$ |
4.45 |
|
|
$ |
7.52 |
|
Consolidated Core and Non-Core |
|||||
|
Nine Months Ended |
||||
|
2020 |
|
2019 |
||
Sales revenue, net |
|
|
|
||
Core |
$ |
1,526,995 |
|
$ |
1,193,454 |
Non-core |
|
62,429 |
|
|
71,613 |
Total |
$ |
1,589,424 |
|
$ |
1,265,067 |
|
Nine Months Ended |
||||
|
2020 |
|
2019 |
||
Adjusted Diluted EPS (non-GAAP) |
|
|
|
||
Core |
$ |
9.58 |
|
$ |
6.98 |
Non-core |
|
0.47 |
|
|
0.44 |
Total |
$ |
10.05 |
|
$ |
7.42 |
|
Nine Months Ended |
||||||
Core Business: |
2020 |
|
2019 |
||||
Diluted EPS, as reported |
$ |
8.67 |
|
|
$ |
5.85 |
|
Acquisition-related expenses, net of tax |
|
— |
|
|
|
0.06 |
|
Restructuring charges, net of tax |
|
0.01 |
|
|
|
0.02 |
|
Tax Reform |
|
(0.37 |
) |
|
|
— |
|
Subtotal |
|
8.31 |
|
|
|
5.93 |
|
Amortization of intangible assets, net of tax |
|
0.51 |
|
|
|
0.38 |
|
Non-cash share-based compensation, net of tax |
|
0.76 |
|
|
|
0.67 |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
9.58 |
|
|
$ |
6.98 |
|
|
|||||||
|
Nine Months Ended |
||||||
Non-Core Business: |
2020 |
|
2019 |
||||
Diluted EPS, as reported |
$ |
0.47 |
|
|
$ |
0.30 |
|
Restructuring charges, net of tax |
|
— |
|
|
|
0.01 |
|
Subtotal |
|
0.47 |
|
|
|
0.31 |
|
Amortization of intangible assets, net of tax |
|
— |
|
|
|
0.12 |
|
Non-cash share-based compensation, net of tax |
|
— |
|
|
|
0.01 |
|
Adjusted Diluted EPS (non-GAAP) |
$ |
0.47 |
|
|
$ |
0.44 |
|
|
|
|
|
||||
Diluted EPS, as reported (GAAP) |
$ |
9.14 |
|
|
$ |
6.15 |
|
Selected Consolidated Balance Sheet, Cash Flow and Liquidity Information
|
|||||
|
|
||||
|
2022 |
|
2021 |
||
Balance Sheet: |
|
|
|
||
Cash and cash equivalents |
$ |
45,337 |
|
$ |
44,344 |
Receivables, net |
|
505,555 |
|
|
505,933 |
Inventory |
|
536,793 |
|
|
585,811 |
Assets held for sale |
|
— |
|
|
2,265 |
Total assets, current |
|
1,122,401 |
|
|
1,164,989 |
Total assets |
|
3,129,425 |
|
|
2,487,405 |
Total liabilities, current |
|
522,702 |
|
|
625,308 |
Total long-term liabilities |
|
1,149,650 |
|
|
507,139 |
Total debt |
|
1,080,460 |
|
|
447,468 |
Stockholders' equity |
|
1,457,073 |
|
|
1,354,958 |
Liquidity: |
|
|
|
||
Working capital |
$ |
599,699 |
|
$ |
539,681 |
|
Nine Months Ended |
||||||
|
2022 |
|
2021 |
||||
Accounts receivable turnover (days) (13) |
|
70.6 |
|
|
|
70.4 |
|
Inventory turnover (times) (13) |
|
2.1 |
|
|
|
2.3 |
|
Working capital |
$ |
599,699 |
|
|
$ |
539,681 |
|
Current ratio |
2.1:1 |
|
1.9:1 |
||||
Ending debt to ending equity ratio |
|
74.2 |
% |
|
|
33.0 |
% |
Return on average equity (13) |
|
10.7 |
% |
|
|
16.4 |
% |
|
Nine Months Ended |
|||||
|
2022 |
|
2021 |
|||
Cash Flow: |
|
|
|
|||
Depreciation and amortization |
$ |
33,330 |
|
$ |
26,082 |
|
Net cash provided (used) by operating activities |
|
49,523 |
|
|
(5,054 |
) |
Capital and intangible asset expenditures |
|
146,194 |
|
|
41,529 |
|
Net debt proceeds |
|
266,452 |
|
|
103,100 |
|
Payments for repurchases of common stock |
|
18,350 |
|
|
113,019 |
|
Reconciliation of Non-GAAP Financial Measures – GAAP Net Cash Provided (Used) by
|
|||||||
|
Nine Months Ended |
||||||
|
2022 |
|
2021 |
||||
Net cash provided (used) by operating activities (GAAP) |
$ |
49,523 |
|
|
$ |
(5,054 |
) |
Less: Capital and intangible asset expenditures |
|
(146,194 |
) |
|
|
(41,529 |
) |
Free cash flow (non-GAAP) |
$ |
(96,671 |
) |
|
$ |
(46,583 |
) |
Updated Fiscal 2023 Outlook for Net Sales Revenue (3)
|
||||||||||||
Consolidated: |
Fiscal 2022 |
|
Updated Outlook for Fiscal 2023 |
|||||||||
Net sales revenue |
$ |
2,223,355 |
|
$ |
2,025,000 |
|
|
— |
|
$ |
2,050,000 |
|
Net sales revenue decline |
|
|
|
(8.9 |
) % |
|
— |
|
|
(7.8 |
) % |
Core Business: |
|
|
|
|||||||||
Net sales revenue |
$ |
2,189,239 |
|
$ |
2,025,000 |
|
|
— |
|
$ |
2,050,000 |
|
Net sales revenue decline |
|
|
|
(7.5 |
) % |
|
— |
|
|
(6.4 |
) % |
|
Reconciliation of Non-GAAP Financial Measures - Updated Fiscal 2023 Outlook for GAAP
|
|||||||||||||||||||||
Consolidated & Core Business |
Nine Months
|
|
Outlook for the
|
|
Updated Outlook
|
||||||||||||||||
Diluted EPS, as reported (GAAP) |
$ |
4.45 |
|
|
$ |
0.37 |
|
— |
|
$ |
0.66 |
|
$ |
4.82 |
|
|
— |
|
$ |
5.11 |
|
Acquisition-related expenses, net of tax |
|
0.12 |
|
|
|
— |
|
— |
|
|
— |
|
|
0.12 |
|
|
— |
|
|
0.12 |
|
|
|
0.90 |
|
|
|
0.02 |
|
— |
|
|
0.01 |
|
|
0.92 |
|
|
— |
|
|
0.91 |
|
Gain from insurance recoveries, net of tax |
|
(0.40 |
) |
|
|
— |
|
— |
|
|
— |
|
|
(0.40 |
) |
|
— |
|
|
(0.40 |
) |
Restructuring charges, net of tax |
|
0.62 |
|
|
|
0.84 |
|
— |
|
|
0.80 |
|
|
1.46 |
|
|
— |
|
|
1.42 |
|
Subtotal |
|
5.69 |
|
|
|
1.23 |
|
— |
|
|
1.47 |
|
|
6.92 |
|
|
— |
|
|
7.16 |
|
Amortization of intangible assets, net of tax |
|
0.50 |
|
|
|
0.19 |
|
— |
|
|
0.17 |
|
|
0.69 |
|
|
— |
|
|
0.67 |
|
Non-cash share-based compensation, net of tax |
|
1.24 |
|
|
|
0.35 |
|
— |
|
|
0.33 |
|
|
1.59 |
|
|
— |
|
|
1.57 |
|
Adjusted diluted EPS (non-GAAP) |
$ |
7.44 |
|
|
$ |
1.76 |
|
— |
|
$ |
1.96 |
|
$ |
9.20 |
|
|
— |
|
$ |
9.40 |
|
Reconciliation of Non-GAAP Financial Measures - Updated Fiscal 2023 Outlook for
|
||||||||||||||||||
Consolidated & Core Business |
Nine Months
|
|
Outlook for the
|
|
Updated Outlook
|
|||||||||||||
Effective tax rate, as reported (GAAP) |
18.6 |
% |
|
30.8 |
% |
|
— |
|
25.7 |
% |
|
19.9 |
% |
|
— |
|
19.5 |
% |
Acquisition-related expenses |
(0.3 |
) % |
|
(0.1 |
) % |
|
— |
|
(0.1 |
) % |
|
(0.3 |
) % |
|
— |
|
(0.3 |
) % |
|
(2.4 |
) % |
|
(0.4 |
) % |
|
— |
|
(0.1 |
) % |
|
(2.1 |
) % |
|
— |
|
(2.0 |
) % |
Gain from insurance recoveries |
1.0 |
% |
|
0.1 |
% |
|
— |
|
— |
% |
|
0.9 |
% |
|
— |
|
0.9 |
% |
Restructuring charges |
(1.5 |
) % |
|
(18.7 |
) % |
|
— |
|
(11.3 |
) % |
|
(3.3 |
) % |
|
— |
|
(3.1 |
) % |
Subtotal |
15.4 |
% |
|
11.7 |
% |
|
— |
|
14.2 |
% |
|
15.1 |
% |
|
— |
|
15.0 |
% |
Amortization of intangible assets |
(0.5 |
) % |
|
(0.5 |
) % |
|
— |
|
(0.4 |
) % |
|
(0.6 |
) % |
|
— |
|
(0.4 |
) % |
Non-cash share-based compensation |
(1.1 |
) % |
|
(1.0 |
) % |
|
— |
|
(0.8 |
) % |
|
(1.4 |
) % |
|
— |
|
(1.0 |
) % |
Adjusted effective tax rate (non-GAAP) |
13.8 |
% |
|
10.2 |
% |
|
— |
|
13.0 |
% |
|
13.1 |
% |
|
— |
|
13.6 |
% |
HELEN OF TROY LIMITED AND SUBSIDIARIES
Notes to Press Release
(1) |
Organic business refers to net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand is acquired, excluding the impact that foreign currency remeasurement had on reported net sales revenue. Net sales revenue from internally developed brands or product lines is considered Organic business activity. |
|
(2) |
The three and nine month periods ended |
|
(3) |
The Company defines Core business as strategic business that it expects to be an ongoing part of its operations, and Non-Core business as business or net assets (including net assets held for sale) that it expects to divest within a year of its designation as Non-Core. |
|
(4) |
Leadership Brand net sales consists of revenue from the OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar brands. |
|
(5) |
Online channel net sales revenue includes direct to consumer online net sales, net sales to retail customers fulfilling end-consumer online orders and net sales to pure-play online retailers. |
|
(6) |
This press release contains non-GAAP financial measures. Adjusted Operating Income, Adjusted Operating Margin, Adjusted Effective Tax Rate, Core Adjusted Effective Tax Rate, Adjusted Income, Adjusted Diluted EPS, Core and Non-Core Adjusted Diluted EPS, EBITDA, Adjusted EBITDA, and Free Cash Flow ("Non-GAAP Financial Measures") that are discussed in the accompanying press release or in the preceding tables may be considered non-GAAP financial information as contemplated by SEC Regulation G, Rule 100. Accordingly, the Company is providing the preceding tables that reconcile these measures to their corresponding GAAP-based measures. The Company believes that these non-GAAP measures provide useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations. The Company believes that these non-GAAP financial measures, in combination with the Company’s financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of certain charges and benefits on applicable income, margin and earnings per share measures. The Company also believes that these non-GAAP measures facilitate a more direct comparison of the Company’s performance with its competitors. The Company further believes that including the excluded charges and benefits would not accurately reflect the underlying performance of the Company’s operations for the period in which the charges and benefits are incurred, even though such charges and benefits may be incurred and reflected in the Company’s GAAP financial results in the near future. The material limitation associated with the use of the non-GAAP measures is that the non-GAAP measures do not reflect the full economic impact of the Company’s activities. These non-GAAP measures are not prepared in accordance with GAAP, are not an alternative to GAAP financial information, and may be calculated differently than non-GAAP financial information disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP information. |
|
(7) |
Charges incurred in conjunction with |
|
(8) |
Gain from insurance recoveries on damaged inventory resulting from a severe weather-related incident that impacted a third-party warehouse facility that the Company used for the Health & Wellness and Beauty segments. |
|
(9) |
Amortization of intangible assets. |
|
(10) |
Non-cash share-based compensation. |
|
(11) |
Charges incurred in connection with the Company’s current restructuring plan, Project Pegasus, and its prior restructuring plan, Project Refuel, which was completed during the fourth quarter of fiscal 2022. |
|
(12) |
Acquisition-related expenses associated with the definitive agreements to acquire Osprey and Curlsmith included in SG&A for the three and nine month periods ended |
|
(13) |
Accounts receivable turnover, inventory turnover and return on average equity computations use 12 month trailing net sales revenue, cost of goods sold or net income components as required by the particular measure. The current and four prior quarters' ending balances of trade accounts receivable, inventory and equity are used for the purposes of computing the average balance component as required by the particular measure. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230105005054/en/
Investor Contact:
(915) 225-4841
(203) 682-8200
Source:
FAQ
What were the net sales for Helen of Troy in Q3 Fiscal 2023?
How did the diluted EPS for Helen of Troy change?
What is the updated earnings outlook for Helen of Troy for Fiscal 2023?